Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.

TSX:SVA - Post by User

Sernova Corp > Patience

<< Previous

Bullboard Posts

Next >>

Post by MoneyMouthon Mar 09, 2021 5:06pm

376 Views

Post# 32755593

Patience

Have some patience until April 27th at the very least. Do you remember this news release from Feb 3rd?

Sernova’s Collaborator to Present Cell Pouch™ Thyroid Transplant Study Results at the American Association of Endocrine Surgeons 2021 Annual Meeting

Two lines in there that you need to read again:

"...Dr. Wiseman’s abstract was selected amongst over 140 abstracts for an Oral Podium Presentation..."

and

"... a resulting journal article will be peer-reviewed for publication consideration in the journal Surgery..."

<< Previous

Bullboard Posts

Next >>

Aston Bay unearths thick new copper zones in Nunavut